Patrick G Enright's Net Worth

$18.2 Million

Who is Patrick G Enright?

Patrick G Enright has an estimated net worth of $18.2 Million. This is based on reported shares across multiple companies, which include VALENTIS INC, Inozyme Pharma, Inc., Lexeo Therapeutics, Inc., Axonics Modulation Technologies, Inc., Vera Therapeutics, Inc., RAPID MICRO BIOSYSTEMS, INC., CORCEPT THERAPEUTICS INC, COLLEGIUM PHARMACEUTICAL, INC, JAZZ PHARMACEUTICALS INC, Esperion Therapeutics, Inc., Tricida, Inc., Talaris Therapeutics, Inc., Sierra Oncology, Inc., Vaxcyte, Inc., 89bio, Inc., Eargo, Inc., Kala Pharmaceuticals, Inc., Venus Concept Inc., THRESHOLD PHARMACEUTICALS INC, Aptinyx Inc., Aimmune Therapeutics, Inc., and SEQUENOM INC.

SEC CIK

Patrick G Enright's CIK is 0001253886

Past Insider Trading and Trends

2020 was Patrick G Enright's most active year for acquiring shares with 13 total transactions. Patrick G Enright's most active month to acquire stocks was the month of July. 2020 was Patrick G Enright's most active year for disposing of shares, totalling 13 transactions. Patrick G Enright's most active month to dispose stocks was the month of July. 2018 saw Patrick G Enright paying a total of $1,908,070.10 for 42,203 shares, this is the most they've acquired in one year. In 2012 Patrick G Enright cashed out on 189,914 shares for a total of $3,206,985.60, their largest year based on trade value.